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Peter D WagnerAbstract
This perspective focuses on key career decisions, explaining the basis of those decisions. In so doing, it exemplifies
the unexpected influences of serendipity and the interaction between serendipity and planned events in shaping
the career of one individual.
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On reading the four preceding Career Perspectives in
this Journal [1-4], one thing becomes clear—styles vary
greatly and, more importantly, focus also varies. Author
instructions encourage reflection on the facts of one's
own contributions to science and on what the future
holds for the author. What is not stressed in the instruc-
tions are what might be the two most useful aspects (for
any young investigators reading this) of the author's scien-
tific research career: First, what career decisions/choices
had to be made, and when and how were those decisions
reached? And second, which contributions to the scientific
journey were more important: (a) simple, logical, linear
thought progression or creativity; (b) hard, sometimes bor-
ing, obsessive/compulsive work behavior or having others
do it for you?; and (c) serendipity or planned ventures?
It is in these two areas—career choices and contribut-
ing factors to research outcomes—that my essay will
concentrate. By using the major research topics of my
past as ‘coat hangers,’ I believe I can achieve the objec-
tives for this perspective as envisioned by the Editors
and at the same time show how and why my path went
in certain directions, and not just of what it was built.Early career choices and decisions
It is relevant that I grew up in Australia in the middle of
the twentieth century. The custom then was to graduate
from high school at age 17 and immediately enter a univer-
sity program (such as a medical school or PhD program)!
Let me stress—for those headed into major programs likeCorrespondence: pdwagner@ucsd.edu
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2013this, the decision of one's life had to be made in the last
year of high school, usually as a 16-year-old, well under the
legal age for drinking, voting, or driving. All I knew at that
age was that I wanted to be a researcher, although my skills
to that point were evident only in the physical and math-
ematical sciences because back then, biology was not even
an optional part of the high school curriculum. Hence, I
was leaning towards a research career in physics or math-
ematics. Foreign languages, English, and History were areas
of forced hard labor where I skated by with little enthu-
siasm but when presented with equations, I was happy. As
the choice deadline approached, I started to fear a possible
sterility inherent in maths and physics research and won-
dered about the challenges I might encounter in biology.
Biophysics was in its relative infancy, and it struck me that
there may be great opportunities to use maths and physics
in biology. For a scholastic prize in high school, I chose
two of the three Otto Glasser volumes titled ‘Medical
Physics’ [5,6] and pored through them. I still possess those
books, half a century later. This was it. Or so I thought.
It was soon brought to my attention that there was an-
other large question to be answered even if I was heading
towards a math/biology research career (despite absolutely
no exposure to biology): Should I do a PhD in math/
physics and try afterwards to pick up some biology? Or
should I go to medical school and continue my math/
physics education on the side, giving up formal PhD
research training in exchange for gaining clinical in-
sights and skills as an investment for the future of this
integrated pathway? I chose the latter, and it was the
best career decision I ever made. Yes, it gave me a sure-
fire plan B if I flunked research, but I would have made
an impossible family doc, I knew it then, and I had noThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Figure 1 Multiple inert gas elimination technique. Bottom panel:
typical retention and excretion curves for a normal subject, showing
the six gases used. Actual data are close to what would be
measured in a truly homogeneous lung. Top panel: the _V A= _Q
distribution derived from these retention and excretion data.
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was the ability to greatly expand my research horizons
by understanding the human body in health and dis-
ease, both biologically and in terms of human experi-
mentation opportunities as a trained physician. It has
been very empowering to initiate and control human
investigation and to be able to perform procedures
such as muscle biopsy and catheter placement—on my
own terms and schedules—and to really understand
the relevance of the physiology I was studying. I had
also gained that hard-to-define element of being a doctor:
to see a patient and recognize something amiss from the
body language, no matter how subtle. Observing the details
(in the presentation of a patient) was inherent to—and crit-
ical for—good medical practice, and, being clearly even
more important in biological research, has served me well.
But I was lacking formal research training, and to rem-
edy that, I interrupted the 6-year medical school curricu-
lum after 4 years to do a 1-year research stint, much like
a modern-day master's. It was then the only realistic op-
portunity for a medical student to learn his way around
the research laboratory. Serendipity stepped in when at a
social event I met Jim McRae, a faculty member in my
medical school interested in radioactive tracer tech-
niques, which were then (1960s) in their infancy. After a
short discussion, I helped, during vacation, with his re-
search [7]. He introduced me to his fellow faculty member
John Read, a noted and brilliant respiratory physician and
researcher who put me onto exploration of serial blood
flow heterogeneity in the rat lung [8] for my 1-year re-
search effort. That worked well, I completed my medical
degree in Sydney (1968), started clinical internship in Syd-
ney (1969), and then faced the next big decision: (A) Hang
up the stethoscope (shouldn't it be stethophone?) after the
intern year and seek overseas postdoctoral research train-
ing or (B) complete my clinical training in internal medi-
cine (2–3 years more for board certification) and then see
what research job might be out there in Australia. The
decision was made easy by more serendipity: Neil
Armstrong's walk on the moon in mid-1969 during my
internship, which created untold enthusiasm for space
biophysics/physiology research.
Postdoctoral fellowship: MIGET
John Read advised me well and I ended up making my
giant leap (for myself, not for mankind) to the University
of California, San Diego (UCSD) to do postdoctoral
work with John West who had just arrived there funded
by NASA to investigate the effects of gravity on the lung
in astronauts during orbital spaceflight. What better chance
to apply maths and physics than to an organ whose primary
function is fully governed by simple convective and diffu-
sive transport processes and the principle of conservation
of mass and at the same time is heavily influenced bygravity—and which reflected a very trendy new area: gravi-
tational physiology? Sadly, soon after arrival, I was told that
space research would be a transient ticket at best and to
look for something more enduring.
For a third time, serendipity shaped my career when
Herb Saltzman from the Duke Hyperbaric Chamber fa-
cility decided to spend a sabbatical with John West ex-
ploring the role of altered barometric pressure on gas
exchange in computer models of the lung that John had
recently developed [9]. These models quantitatively pre-
dicted how heterogeneity in ventilation and blood flow
in the lung would affect O2 and CO2 exchange. Herb
and I, still an early postdoc, spoke for hours about this,
the discussion evolving into whether we could ‘reverse
the arrow’ and use the very same models in the opposite
direction: use gas exchange measurements to infer het-
erogeneity in distribution of ventilation and blood flow
in the lungs. In a very logical manner, we explored the
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ation technique (MIGET) was born (Figure 1) [10,11],
probably recognized as my major contribution to science
over the years. My publications list, which I will neither
cite—nor recite—here, testifies to the development and
application of MIGET to probe the physiology of health
and the pathophysiology of cardiopulmonary disease over
the ensuing quarter century and beyond. The appeal of
MIGET to me was in the essential nature of substantial
mathematics to solve biological problems. However,
MIGET rapidly produced a flood of critics who said I
had built a mathematical house of cards. I knew it was
solid, but lacked the math skills to convince my critics.
Enter John Evans, a fellow faculty member at UCSD.VENTILATION / PERFUSION  RATIO
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Figure 2 MIGET results typical of patients with common cardiopulmo
asthma. Bottom panel: retention and excretion curves, showing the gases u
solubility gases is increased (arrow). Top panel: the associated _V A= _Q distribu
typical of patients with either emphysema or pulmonary embolism. Bottom
circles). Compared to homogeneous, excretion of higher solubility gases is
showing the appearance of areas of high _V A= _Q . (C) MIGET results typical o
and also very low _V A= _Q ratio are common, but the pattern is quite differen
patients with acute lung injury. Areas of zero (i.e., shunt) and also very lowJohn was a trained physician (this was so important to
this story: I had approached mathematicians who had
no biology exposure and I simply could not communi-
cate with them). John had abandoned medicine years
before and had become a professional mathematician
instead. As a physician, he saw the value in what I was
trying to do and, as a mathematician, found a way to
keep the baby while getting rid of the bath water. He
produced an algorithm for MIGET [12] to replace my
clumsy, brute force approach. This algorithm was based
on very transparent and solid matrix inversion principles
and showed that MIGET was in no way a house of cards.
Single-handedly, John brought respect to MIGET. Very
predictably, we went on to make original observations ofVENTILATION / PERFUSION  RATIO
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nary disorders. (A) MIGET results typical of patients with moderate
sed (solid circles). Compared to homogeneous, retention of lower
tion, showing the appearance of areas of low _V A= _Q . (B) MIGET results
panel: retention and excretion curves, showing the gases used (solid
decreased (arrow). Top panel: the associated _V A= _Q distribution,
f patients with interstitial pulmonary fibrosis. Areas of zero (i.e., shunt)
t from that seen in asthma (Figure 2A). (D) MIGET results typical of
_V A= _Q ratio are common, as are high _V A= _Q regions.
DATA  FROM  OPERATION  EVEREST II
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Figure 3 MIGET results in normal subjects during a simulated
ascent of the Everest summit. Inequality, expressed as the second
moment of the distribution on a log scale (LOG SD Q), is variable
but surprisingly high, especially at a barometric pressure (PB) = 347
mm Hg when subjects were ascending quickly. This likely reflects
some degree of high-altitude pulmonary edema. Data from [14].
ALL  SUBJECTS
Mixed Venous PO2, mm Hg














OPERATION  EVEREST  II
Data from Sutton et al. J. Applied Physiology 64:1309-1321, 1988
PB=760mm Hg
PB=347mm Hg
Figure 5 PvO2 and _VO2MAX (mean ± sd) at sea level and PB =
347 mm Hg in all subjects. As for subject 1 (Figure 4), PvO2 and
_V O2 relate essentially in direct proportion to one another (dashed
line). Data from [25].
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http://www.extremephysiolmed.com/content/2/1/31ventilation/perfusion inequality in basically all the com-
mon cardiopulmonary disorders (Figure 2) as well as in
healthy humans during exercise and at altitude. We fo-
cused on exercise and altitude, alone and together, be-
cause that was when gas exchange was stressed to its
limits, offering the best chance to probe the factors that
limit gas exchange.Operation Everest II
Serendipity now stepped in for a fourth time: Operation
Everest II [13]. This remarkable event took place in the
fall of 1985 in Natick, MA, USA, at the USARIEM.VO2,  L/min
















OPERATION  EVEREST  II
Data from Sutton et al. J. Applied Physiology 64:1309-1321, 1988
SUBJECT 1
Figure 4 PvO2 from rest to peak exercise at sea level and PB =
347 mm Hg in one subject. At each altitude, during a simulated
ascent of the Everest summit, PvO2 falls with increasing exercise
intensity but is much lower at altitude than at sea level at any _V O2.
At peak _V O2, PvO2 and _V O2 relate in direct proportion to one
another (dashed line). Data from [25].Organized by Allen Cymerman, the late Charlie Hous-
ton, and the late John Sutton, it brought together more
than 20 principal investigators and their teams to study
every major system, both at rest and during exercise, at
sea level and then all the way to the (simulated) summit
of Mt. Everest, in a brave group of young fit subjects. I
was asked to be the lung gas exchange investigator, using
MIGET, and the task was completed [14]. The degree of
gas exchange impairment at extreme altitude was aston-
ishing (Figure 3 uses data from OEII)—approaching
levels that at sea level would put patients into the ICU.FICK PRINCIPLE (CONVECTION):  VO2  =  Q  x  [CaO2  -  CvO2]
FICK LAW (DIFFUSION):                  VO2  =  D  x  constant x  PvO2
MUSCLE  VENOUS  PO2  ,  mm Hg
































Figure 6 The Fick diagram. _V O2 plotted against PvO2 showing the
two transport equations: the Fick principle of convective O2
transport by the circulation and the Fick law of diffusive O2 transport
from the capillary to the mitochondrion. By conservation of mass
principles, the only feasible point is the solid circle, showing how
_V O2MAX must be determined by the integrated effects of peak
blood flow Q, diffusion D, and arterial [O2] CaO2. Modified from [16].
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needed for MIGET: the PO2 in the pulmonary arterial blood.
I looked at this variable because a then-unanswered ques-
tion was whether the PO2 in the muscle venous blood had
some lower limit (below which it could not fall) and still get
O2 to the mitochondria. I realized we had a completely
unique data set for this question: pulmonary arterial blood
gas values at (essentially) maximal exercise not just at sea
level but at simulated altitudes of about 20,000, 25,000, and
29,000 ft. Although not a sample of muscle venous blood,
such data must be dominated by, and thus reflect, PO2






Figure 7 Cross section of mouse medial gastrocnemius stained for ca
Cre Recombinase, which cleaves any LoxP sequences present on the VEGF
capillarity is unaffected. Adapted from [19]. (B) Area outlined is the small re
mouse, and capillarity is clearly diminished in the transfected region. Adapexercise. Surely at these altitude extremes, we would readily
be able to see if there was some lower limit to venous PO2.
Figure 4 shows what we found in a typical subject: At
any exercise level, including maximal, PvO2 was lower at
altitude than at sea level. As I thought more, I became
very perplexed by this actually extremely simple finding—
If PvO2 during maximal exercise at 20,000 ft was less than
PvO2 during maximal exercise at sea level, why did PvO2
not fall further at sea level—enabling even more exercise—
until it equaled the PvO2 observed at 20,000 ft? There
must be a barrier to O2 extraction at sea level—and a bar-
















pillaries (black). (A) Area outlined is the small region injected with
gene. This was a control mouse without LoxP sequences, and
gion injected with Cre Recombinase. This was a VEGF-LoxP transgenic
ted from [19].
Figure 8 Abysmal physical performance in muscle-specific
VEGF k/o mice. Adapted from [20].
Wagner Extreme Physiology & Medicine Page 6 of 82013, 2:31
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exercise and of _V O2MAX . Heresy! _V O2MAX is limited by
cardiac output/muscle blood flow. Barclay and Stainsby
and others had said so [15].
Then came the next, equally simple, revelation from
Figure 4: I could draw a pretty good straight line
connecting the values of PvO2 at maximal exercise to the
origin. Was this just by chance in this subject? I quickly
checked the other subjects' data and found the same
thing: a linear relationship through the origin between
_V O2MAX and PvO2 at maximal exercise, albeit each
subject's line had a somewhat different slope. Mean re-
sults are shown in Figure 5. This linearity could not be
chance and thus must be telling us something very sig-
nificant about the rules governing O2 extraction. Light
bulb momentc Realizing that _V O2 was a flux and that
PvO2 represented the PO2 diffusion gradient between
muscle blood and mitochondria (assuming very low
mitochondrial PO2 as had been suspected for a long
time), I reasoned that perhaps _V O2 (X-axis, Figure 3)
was not dictating PvO2 (Y-axis, Figure 3), but vice
versa: That the capacity for diffusion of O2 between
muscle blood and mitochondria was limited, and that
this in turn limited _V O2MAX. So was born the Fick dia-
gram [16] (Figure 6), where _V O2 is plotted against
PvO2 simultaneously for the two operating transport
processes: (a) convective conductance by blood flow of
O2 into the muscle vascular bed (and back out into the
muscle veins) and (b) diffusive transport of O2 from
muscle blood vessels to mitochondria. The transport
equations for these two processes are straightforward, and
it soon became evident that _V O2MAX was the integrated
outcome of both processes—it was given by the point of
intersection of the two transport equations, a point whose
location was the result of how large or small were a few key
variables: muscle blood flow, arterial O2 concentration
(broken down into [Hb] and arterial O2 saturation), and
muscle tissue diffusional conductance for O2. Why was the
intersection point the position of interest? Because that was
the only point on the entire graph where _V O2 determined
from both of the processes was the same at the same ven-
ous PO2—that is, the only point where oxygen mass was
conserved in its transfer from blood to mitochondria.
It was no longer heresy to claim that within-muscle diffu-
sion was a factor in _V O2MAX as Figure 6 allowed Barclay and
Stainsby to still be correct in saying that blood flow was im-
portant. Figure 6 expanded the understanding of limits to
_V O2MAX. as being due to the behavior of the entire O2 trans-
port chain as a system, and not due to just one component
of that system. _V O2MAX was the result of how the lungs,
heart, and muscles worked as an integrated O2 transport
system, with each component able to affect the final result.From a 30,000-ft viewpoint (actually 29,000 ft), it be-
came evident that a completely serendipitous observa-
tion about venous PO2 during Operation Everest II led
to an entirely new area of investigation and way of think-
ing about how _V O2MAX is limited.Enter molecular biology
The Fick law of diffusion alleges that both surface area
and distance affect diffusive flux through any tissue, as
textbooks such as that of West [17] clearly assert. Thus,
the next question is, was it more surface area (which im-
plies capillarity) or diffusion distance (which implies
fiber area) that determined the finite muscle O2 diffu-
sional conductance? In the mid-1990s the Physiology
Division at UCSD was probably the only lung research
center on the planet not engaged in research at the mo-
lecular level. When it became evident that capillarity
was the key determinant of muscle diffusive properties,
we embarked on a predictable, laborious journey to
understand how muscle capillary numbers were regu-
lated. Many years later, we have pretty well established
that one growth factor, vascular endothelial growth fac-
tor (VEGF), single-handedly rules muscle capillarity in-
sofar as when VEGF is deleted, (a) muscle capillaries
regress (Figure 7), and (b) there is no functional adaptive
response to enforced exercise training: VEGF-deficient
mice cannot be trained and have perhaps one-fifth the
endurance capacity of normal mice (Figure 8) [18-20].
Much of my effort the past several years has focused on
trying to understand how and why VEGF is so important,
and it may all come down to one elegant, unifying effect
of exercise: intracellular hypoxia in the myocyte. As
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high—perhaps 30 mm Hg. However, within seconds of
starting exercise, PO2 falls dramatically: to about 3–4
mm Hg [22]. This may do many things that all benefit
exercise simultaneously:
 Leave enough of a PO2 to adequately drive oxidative
phosphorylation [23]
 Maximize the capillary-mitochondrion O2 diffusion
gradient to enhance O2 availability
 Cause local vasodilatation to increase blood flow,
matching it, and thus also O2 delivery, to local
metabolic rate
 Stimulate adaptive gene transcription to provide a
mechanism for training
It is well known [24] that many of the genes in-
volved in muscle function are hypoxically stimulated
via HIF, and VEGF is one of them. This attractive,
holistic theory needs to be better evaluated but is very
promising.
With that I will close this short story—since it brings
me to the present—with answers to the initial questions I
posed:
‘First, what career decisions/choices had to be made,
and when, and how were those decisions reached?’
These have been answered above and bear no
repetition here.‘And second, which contributions to the scientific
journey were more important? a) simple, logical,
linear, thought progression or creativity? b) hard,
sometimes boring, obsessive/compulsive work
behavior or having others do it for you? and c)
serendipity or planned ventures?’The answers, simply, are ‘yes, yes, and yes.’Abbreviations
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